Cover ImageSALE
市場調查報告書

組織支架材料的全球市場:2018年∼2022年

Global Tissue Scaffolds Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 603610
出版日期 內容資訊 英文 131 Pages
訂單完成後即時交付
價格
Back to Top
組織支架材料的全球市場:2018年∼2022年 Global Tissue Scaffolds Market 2018-2022
出版日期: 2018年02月06日 內容資訊: 英文 131 Pages
簡介

關於組織支架材料

組織支架是由天然或合成的生物相容性材料組成的細胞生長支持結構,為細胞增殖和分化提供有利的環境。

Technavio的分析師預測,從2018年到2022年之間,全球組織支架材料市場將以12.14%的年複合成長率成長。

本報告提供全球組織支架材料市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模與預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形

第7章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:各產品
  • 天然組織支架材料
  • 合成組織支架材料
  • 市場機會:各產品

第8章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 比較:各應用領域
  • 肌肉骨骼
  • 皮膚科
  • 心臟血管
  • 其他

第9章 客戶形勢

第10章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 主要的已開發國家
  • 市場機會:各地區

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • 擴大的M&A與策略性合作
  • 技術進步的擴大

第14章 業者情勢

  • 概要
  • 創造性破壞
  • 競爭模式

第15章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • 其他有力的供應商

第16章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR20852

About Tissue Scaffolds

Tissue scaffolds are cell growth supporting structures composed of natural or synthetic biocompatible materials that provide a favorable environment for cell proliferation and differentiation.

Technavio's analysts forecast the global tissue scaffolds market to grow at a CAGR of 12.14% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue scaffolds market for 2018-2022. To calculate the market size, the report considers the revenue generated from the tissue scaffolds.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tissue Scaffolds Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew

Market driver

  • Growing occurrence of chronic and acute wounds
  • For a full, detailed list, view our report

Market challenge

  • Limitations of tissue scaffolds
  • For a full, detailed list, view our report

Market trend

  • Increasing technological advances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Natural tissue scaffolds
  • Synthetic tissue scaffolds
  • Market opportunity by product

PART 08: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Musculoskeletal
  • Dermatological
  • Cardiovascular
  • Others

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Tissue scaffolds market in Americas
  • Tissue scaffolds market in EMEA
  • Tissue scaffolds market in APAC
  • Key leading countries
  • Market opportunity by region

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Growing M&A and strategic collaborations
  • Increasing technological advances

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bioventus
  • Integra Lifesciences
  • MiMedx Group
  • Organogenesis
  • RTI Surgical
  • Smith & Nephew
  • Other prominent vendors

PART 16: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global regenerative medicine market: Segmentation
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global tissue scaffolds market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global tissue scaffolds market - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global tissue scaffolds market - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global natural tissue scaffolds market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global natural tissue scaffolds market - Year over year growth 2018-2022 (%)
  • Exhibit 22: Global synthetic tissue scaffolds market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global synthetic tissue scaffolds market - Year over year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Tissue scaffold market by application - Market share 2017-2022 (%)
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global tissue scaffolds market - Market share by region 2017-2022 (%)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Tissue scaffolds market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 30: Tissue scaffolds market in Americas - Year over year growth 2018-2022 (%)
  • Exhibit 31: Top two countries in Americas
  • Exhibit 32: Tissue scaffolds market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Tissue scaffolds market in EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 34: Top two countries in EMEA
  • Exhibit 35: Tissue scaffolds market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: Tissue scaffolds market in APAC - Year over year growth 2018-2022 (%)
  • Exhibit 37: Top two countries in APAC
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity by geography
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Competitive structure analysis of global tissue scaffolds market 2017
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Bioventus: Overview
  • Exhibit 47: Bioventus: Business segments
  • Exhibit 48: Bioventus: Organizational developments
  • Exhibit 49: Bioventus: Geographic focus
  • Exhibit 50: Bioventus: Segment focus
  • Exhibit 51: Bioventus: Key offerings
  • Exhibit 52: Bioventus: Key customers
  • Exhibit 53: Integra LifeSciences: Overview
  • Exhibit 54: Integra LifeSciences: Business segments
  • Exhibit 55: Integra LifeSciences: Organizational developments
  • Exhibit 56: Integra LifeSciences: Geographic focus
  • Exhibit 57: Integra LifeSciences: Segment focus
  • Exhibit 58: Integra LifeSciences: Key offerings
  • Exhibit 59: Integra LifeSciences: Key customers
  • Exhibit 60: MiMedx Group: Overview
  • Exhibit 61: MiMedx Group: Business segments
  • Exhibit 62: MiMedx Group: Organizational developments
  • Exhibit 63: MiMedx Group: Geographic focus
  • Exhibit 64: MidMedx Group: Segment focus
  • Exhibit 65: MidMedx Group: Key offerings
  • Exhibit 66: MiMedx Group: Key customers
  • Exhibit 67: Organogenesis: Overview
  • Exhibit 68: Organogenesis: Business segments
  • Exhibit 69: Organogenesis: Organizational developments
  • Exhibit 70: Organogenesis: Geographic focus
  • Exhibit 71: Organogenesis: Segment focus
  • Exhibit 72: Organogenesis: Key offerings
  • Exhibit 73: Organogenesis: Key customers
  • Exhibit 74: RTI Surgical: Overview
  • Exhibit 75: RTI Surgical: Business segments
  • Exhibit 76: RTI Surgical: Organizational developments
  • Exhibit 77: RTI Surgical: Geographic focus
  • Exhibit 78: RTI Surgical: Segment focus
  • Exhibit 79: RTI Surgical: Key offerings
  • Exhibit 80: RTI Surgical: Key customers
  • Exhibit 81: Smith & Nephew: Overview
  • Exhibit 82: Smith & Nephew: Business segments
  • Exhibit 83: Smith & Nephew: Organizational developments
  • Exhibit 84: Smith & Nephew: Geographic focus
  • Exhibit 85: Smith & Nephew: Segment focus
  • Exhibit 86: Smith & Nephew: Key offerings
  • Exhibit 87: Smith & Nephew: Key customers
Back to Top